John Dudley Isaacs
Newcastle University
H-index: 88
Europe-United Kingdom
Top articles of John Dudley Isaacs
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
A proteomics study of rheumatoid arthritis patients on etanercept identifies putative biomarkers associated with clinical outcome measures | Rheumatology | Stephanie F Ling Chuan Fu Yap Nisha Nair James Bluett Ann W Morgan | 2024/4/1 |
Role of IFN-α in Rheumatoid Arthritis | Chung MA Lin John D Isaacs Faye AH Cooles | 2024/2 | |
Personalised care packages for people with rheumatoid arthritis: a mixed-methods study | RMD open | Mrinalini Dey Amanda Busby John D Isaacs Arthur Pratt Mwidimi Ndosi | 2024/1/1 |
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2023 | Annals of the rheumatic diseases | Kevin L Winthrop Philip Mease Andreas Kerschbaumer Reinhard E Voll Ferdinand C Breedveld | 2024/4/1 |
Differential properties of Janus kinase inhibitors in the treatment of immune-mediated inflammatory diseases | Peter C Taylor Ernest Choy Xenofon Baraliakos Zoltan Szekanecz Ricardo M Xavier | 2024/2/1 | |
HLA-DRB1 and HLA-DQA1 associated with immunogenicity to adalimumab therapy in patients with rheumatoid arthritis | Annals of the rheumatic diseases | Chuan Fu Yap Nisha Nair Annick de Vries Floris C Loeff Ann W Morgan | 2024/2/1 |
Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial | The Lancet | Andrew P Cope Marianna Jasenecova Joana C Vasconcelos Andrew Filer Karim Raza | 2024/2/13 |
CAR T Cells—A New Horizon for Autoimmunity? | N Engl J Med | John D Isaacs | 2024 |
OA40 Clinical and psychological factors associated with adherence based on a patient self-reported questionnaire: results from the biologics in rheumatoid arthritis genetics … | Timothy KY Chong Nisha Nair Ann W Morgan John D Isaacs Anthony G Wilson | 2024/4/1 | |
Single-cell insights into immune dysregulation in rheumatoid arthritis flare versus drug-free remission | Nature Communications | Kenneth F Baker David McDonald Gillian Hulme Rafiqul Hussain Jonathan Coxhead | 2024/2/5 |
Operational complexities in international clinical trials: a systematic review of challenges and proposed solutions | Leher Gumber Opeyemi Agbeleye Alex Inskip Ross Fairbairn Madeleine Still | 2024/4/1 | |
Adenosine metabolic signature in circulating CD4+ T cells predicts remission in rheumatoid arthritis | RMD open | Philip M Brown Amy E Anderson Najib Naamane Dennis W Lendrem Ann W Morgan | 2024/2/1 |
Endogenous retroelement activation is implicated in IFN-alpha production and anti-CCP autoantibody generation in early RA | medRxiv | Faye AH Cooles Gemma Vidal-Pedrola Najib Naamane Arthur G Pratt Ben Millar | 2024 |
OP0103 ANALYSIS OF PROTEIN QUANTITATIVE TRAIL LOCI TO IDENTIFY GENETIC BIOMARKERS OF TREATMENT RESPONSE TO ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS | Stephanie Ling Chuan Fu Yap Nisha Nair J Bluett A Morgan | 2023/6/1 | |
Enhancing quality and impact of early phase dose-finding clinical trial protocols: SPIRIT Dose-finding Extension (SPIRIT-DEFINE) guidance | bmj | Christina Yap Jan Rekowski Moreno Ursino Olga Solovyeva Dhrusti Patel | 2023/10/20 |
OA03 Harnessing quantitative proteomics to identify biomarkers of treatment response to etanercept in patients with rheumatoid arthritis | Rheumatology | Stephanie F Ling Chuan Fu Yap Nisha Nair James Bluett Ann W Morgan | 2023/4/1 |
PRECISION MEDICINE IN RHEUMATOID ARTHRITIS | Kartik Bhamidipati Kevin Wei | 2022/3/1 | |
Micro-RNA content of circulating extracellular vesicles in early rheumatoid arthritis as biomarkers and mediators of methotrexate efficacy | Rheumatology | Daniel Maunder Philip M Brown Ben Barron-Millar Dennis W Lendrem Najib Naamane | 2023/11/1 |
Non-trough adalimumab and certolizumab drug levels associated with a therapeutic EULAR response in adherent patients with rheumatoid arthritis | Rheumatology | Ryan M Hum Pauline Ho Nisha Nair Meghna Jani Ann W Morgan | 2023/6/1 |
P037 The NIHR IMID Bioresource: a descriptive analysis of the first 5000 participants | Rheumatology | Sarah Dyball Ed Vital Sven Plein Dennis McGonagle Arthur G Pratt | 2023/4/1 |
